acetaminophen vs adalimumab
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of acetaminophen and adalimumab. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Tylenol
Humira
Acetaminophen (Tylenol) is a medicine that can relieve pain and reduce fever. It is available over-the-counter.
Idacio is a medicine that blocks a protein called TNF. It is used to treat several diseases, including arthritis and Crohn's disease.
This medicine temporarily relieves minor aches and pains. It can help with headaches, the common cold, backaches, and minor arthritis pain. It can also help with toothaches, muscle aches, premenstrual and menstrual cramps. Acetaminophen can also temporarily reduce fever.
Idacio can help adults with rheumatoid arthritis by reducing joint pain and damage. It can also help children (2 years and older) with juvenile idiopathic arthritis. Idacio treats psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa and uveitis.
Acetaminophen's exact mechanism is not fully understood. It is believed to work in the brain to reduce pain signals. It also helps to lower body temperature when you have a fever.
Idacio works by blocking a protein in your body called tumor necrosis factor (TNF). TNF can cause inflammation and damage in certain diseases. By blocking TNF, Idacio can reduce these symptoms.
- • Headache
- • Nausea
- • Infections (like colds or sinus infections)
- • Injection site reactions (redness, itching, pain, or swelling)
- • Headache
- • Rash
- Fatigue 34,487
- Nausea 29,567
- Headache 28,380
- Pain 28,314
- Diarrhoea 23,626
- Pain 49,062
- Arthralgia 48,039
- Injection Site Pain 47,251
- Fatigue 39,111
- Rheumatoid Arthritis 35,573
Taking more acetaminophen than directed can cause liver damage. Follow the dosage instructions carefully.
Idacio can increase your risk of serious infections that could lead to hospitalization or death. Tell your doctor if you have any infections before starting Idacio. Idacio may also increase your risk of certain cancers, including lymphoma. Children and teens taking TNF blockers like Idacio have developed rare, aggressive cancers.
If you are pregnant or breastfeeding, talk to your doctor before using this medicine. They can help you weigh the risks and benefits.
Tell your doctor if you are pregnant or plan to become pregnant. Idacio can cross the placenta and may affect your baby's immune system. Talk to your doctor about vaccines for your baby if you took Idacio during pregnancy.
Also Compare, Nearby Drugs
Compare adalimumab with
How to Read This acetaminophen vs adalimumab Comparison
acetaminophen is classified in the Analgesic / Antipyretic drug class, while adalimumab sits within the TNF-Alpha Inhibitor (Biologic) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are split between OTC and prescription status, which affects access and supervision.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, acetaminophen has 144,374 submissions while adalimumab has 219,036. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for acetaminophen or adalimumab.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.